Entity > Corporation > US > New York City New York > Celgene

About Celgene

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Celgene

Company Attribute Value
Name Celgene
Url celgene
Google google
Wikidata wikidata



New York City, US
1 Oct 2023

New York City, US
1 Oct 2023


Page: 1 Desktop | Laptop Devices

Bristol Myers Squibb: Global Biopharmaceutical Company
Acquisition-related information for Celgene shareholders · Investor contacts. QUICK LINKS. Annual Report 2022 > · Dividend history > · Stock split history ...
https://www.celgene.com › research-development › cli...
Clinical Trials Data Sharing - Celgene Corp.
Celgene is committed to responsible and transparent sharing of clinical trial data with patients, healthcare practitioners and independent researchers for ...
https://www.biospace.com › employer › celgene
Articles about Celgene
As a global leader in biotechnology and CAR T cell therapy, Celgene is a place where employees can make a real impact on the lives of patients with unmet ...
https://www.globaldata.com › All Companies
Celgene Corp Company Profile
Celgene Corp (Celgene), a subsidiary of Bristol-Myers Squibb Co, is an integrated biopharmaceutical company that discovers, develops, manufactures, and ...
https://www.ftc.gov › browse › cases-proceedings › 1...
Bristol-Myers Squibb Company and Celgene Corporation, ...
Pharmaceutical and biologic manufacturers Bristol-Myers Squibb Company and Celgene Corporation agreed to divest Celgene's Otezla, the most popular oral ...
https://en.wikipedia.org › wiki › Celgene
Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the ...
Places / GMB
Places / GMB
Celgene: A Global Biopharmaceutical Company Committed to ...
Search www.celgene.com.au · Celgene is a Bristol Myers Squibb company. · Creating an Innovative Biopharma Leader with Global Reach and Scale · A Decade of Progress ...
https://www.justice.gov › usao-cdca › celgene-agrees-...
Celgene Agrees to Pay $280 Million to Resolve Fraud ...
Jul 24, 2017 — LOS ANGELES – Celgene Corp., a manufacturer of pharmaceuticals headquartered in Summit, New Jersey, has agreed to pay $280 million to settle ...
Entities Box
Entities Box
Bristol-Myers Squibb subsidiaries
Related Searches
Related Searches
Celgene stock
celgene i-access
celgene products
Knowledge Panel
Knowledge Panel

Celgene (Pharmaceutical company)


Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid, which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb.

  • Parent organization : Bristol Myers Squibb
  • Subsidiaries : Celgene Co, Celgene Pty, Signal Pharmaceuticals, MORE
  • CEO : Mark J. Alles (Mar 1, 2016–)
  • Headquarters : Summit, NJ
  • Revenue : 15.28 billion USD (2018)
  • Founder : Sol J. Barer
  • Founded : April 17, 1986

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 86827